nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—CHRFAM7A—corpus luteum—hypothyroidism	0.16	0.191	CbGeAlD
Methylphenobarbital—CHRNA7—corpus luteum—hypothyroidism	0.129	0.155	CbGeAlD
Methylphenobarbital—GRIK2—cerebellar cortex—hypothyroidism	0.0978	0.117	CbGeAlD
Methylphenobarbital—CHRNA4—cochlea—hypothyroidism	0.0716	0.0856	CbGeAlD
Methylphenobarbital—GRIK2—nerve—hypothyroidism	0.0358	0.0428	CbGeAlD
Methylphenobarbital—CHRNA4—nerve—hypothyroidism	0.0288	0.0344	CbGeAlD
Methylphenobarbital—CYP2C19—urine—hypothyroidism	0.0272	0.0325	CbGeAlD
Methylphenobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0138	0.0843	CbGpPWpGaD
Methylphenobarbital—GRIK2—heart—hypothyroidism	0.0133	0.0159	CbGeAlD
Methylphenobarbital—GABRA4—heart—hypothyroidism	0.0125	0.015	CbGeAlD
Methylphenobarbital—CHRNA7—heart—hypothyroidism	0.0108	0.013	CbGeAlD
Methylphenobarbital—GABRA4—pituitary gland—hypothyroidism	0.0105	0.0125	CbGeAlD
Methylphenobarbital—CHRNA7—cardiovascular system—hypothyroidism	0.0102	0.0122	CbGeAlD
Methylphenobarbital—CHRNA4—cardiovascular system—hypothyroidism	0.0101	0.0121	CbGeAlD
Methylphenobarbital—CHRFAM7A—blood—hypothyroidism	0.01	0.012	CbGeAlD
Methylphenobarbital—CHRFAM7A—thyroid gland—hypothyroidism	0.00967	0.0116	CbGeAlD
Methylphenobarbital—CHRFAM7A—female gonad—hypothyroidism	0.00934	0.0112	CbGeAlD
Methylphenobarbital—GABRA3—thyroid gland—hypothyroidism	0.00926	0.0111	CbGeAlD
Methylphenobarbital—GRIA2—testis—hypothyroidism	0.00909	0.0109	CbGeAlD
Methylphenobarbital—GABRA5—testis—hypothyroidism	0.00852	0.0102	CbGeAlD
Methylphenobarbital—GRIA2—cerebellum—hypothyroidism	0.0084	0.01	CbGeAlD
Methylphenobarbital—CHRFAM7A—testis—hypothyroidism	0.00828	0.0099	CbGeAlD
Methylphenobarbital—GABRA6—cerebellum—hypothyroidism	0.00811	0.0097	CbGeAlD
Methylphenobarbital—CHRNA7—adrenal gland—hypothyroidism	0.00809	0.00967	CbGeAlD
Methylphenobarbital—CHRNA7—blood—hypothyroidism	0.00809	0.00967	CbGeAlD
Methylphenobarbital—CHRNA4—adrenal gland—hypothyroidism	0.00798	0.00954	CbGeAlD
Methylphenobarbital—GABRA3—testis—hypothyroidism	0.00793	0.00948	CbGeAlD
Methylphenobarbital—CHRNA7—thyroid gland—hypothyroidism	0.00781	0.00933	CbGeAlD
Methylphenobarbital—GRIK2—cerebellum—hypothyroidism	0.00759	0.00907	CbGeAlD
Methylphenobarbital—CHRNA7—female gonad—hypothyroidism	0.00754	0.00902	CbGeAlD
Methylphenobarbital—GABRA2—adrenal gland—hypothyroidism	0.00714	0.00854	CbGeAlD
Methylphenobarbital—GABRA4—cerebellum—hypothyroidism	0.00714	0.00854	CbGeAlD
Methylphenobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00682	0.0417	CbGpPWpGaD
Methylphenobarbital—CHRNA7—testis—hypothyroidism	0.00669	0.008	CbGeAlD
Methylphenobarbital—CHRNA4—cerebellum—hypothyroidism	0.0061	0.00729	CbGeAlD
Methylphenobarbital—CYP2B6—adrenal cortex—hypothyroidism	0.00564	0.00674	CbGeAlD
Methylphenobarbital—GABRA2—cerebellum—hypothyroidism	0.00546	0.00652	CbGeAlD
Methylphenobarbital—CYP2B6—heart—hypothyroidism	0.00545	0.00652	CbGeAlD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0053	0.0324	CbGpPWpGaD
Methylphenobarbital—GABRA1—cerebellum—hypothyroidism	0.00527	0.0063	CbGeAlD
Methylphenobarbital—CYP2C19—blood—hypothyroidism	0.0052	0.00621	CbGeAlD
Methylphenobarbital—CYP2B6—cardiovascular system—hypothyroidism	0.00515	0.00615	CbGeAlD
Methylphenobarbital—CYP2B6—gonad—hypothyroidism	0.00467	0.00558	CbGeAlD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00432	0.0264	CbGpPWpGaD
Methylphenobarbital—CYP2B6—adrenal gland—hypothyroidism	0.00407	0.00487	CbGeAlD
Methylphenobarbital—CYP2B6—blood—hypothyroidism	0.00407	0.00487	CbGeAlD
Methylphenobarbital—CYP2C19—liver—hypothyroidism	0.00407	0.00486	CbGeAlD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00389	0.0238	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00354	0.0217	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00342	0.0209	CbGpPWpGaD
Methylphenobarbital—CYP2B6—testis—hypothyroidism	0.00337	0.00402	CbGeAlD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00334	0.0204	CbGpPWpGaD
Methylphenobarbital—CYP2B6—liver—hypothyroidism	0.00318	0.0038	CbGeAlD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00304	0.0186	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—SLC5A7—hypothyroidism	0.00298	0.0182	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00298	0.0182	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00289	0.0177	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00278	0.017	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—SLC5A7—hypothyroidism	0.00271	0.0166	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00268	0.0164	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00255	0.0156	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00251	0.0153	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00248	0.0151	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00248	0.0151	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00244	0.015	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00228	0.014	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—SLC5A7—hypothyroidism	0.00228	0.014	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—SLC5A7—hypothyroidism	0.00221	0.0135	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00217	0.0133	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00213	0.0131	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00212	0.013	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0021	0.0128	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0021	0.0128	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—NEFL—hypothyroidism	0.00192	0.0118	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00192	0.0117	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—SLC5A7—hypothyroidism	0.0019	0.0116	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—SLC5A7—hypothyroidism	0.00187	0.0115	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00186	0.0114	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00186	0.0114	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00183	0.0112	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0018	0.011	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00179	0.0109	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—NEFL—hypothyroidism	0.00175	0.0107	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00172	0.0105	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.00166	0.0102	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.00163	0.01	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.00161	0.00983	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.0016	0.00976	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00158	0.00964	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00153	0.00937	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—NEFL—hypothyroidism	0.00147	0.00899	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—NEFL—hypothyroidism	0.00143	0.00872	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.0014	0.00856	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00137	0.00841	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.00137	0.00838	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00136	0.00832	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00135	0.00826	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—VAV3—hypothyroidism	0.00126	0.00774	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—NEFL—hypothyroidism	0.00122	0.00748	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—NEFL—hypothyroidism	0.00121	0.00738	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00115	0.00705	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00111	0.00678	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—NEFL—hypothyroidism	0.00107	0.00656	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—NEFL—hypothyroidism	0.00105	0.00644	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—NEFL—hypothyroidism	0.00104	0.00633	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00102	0.00624	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00101	0.00616	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000895	0.00547	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000883	0.0054	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000879	0.00538	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000864	0.00528	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000845	0.00517	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000835	0.00511	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000742	0.00454	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000736	0.00451	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000728	0.00445	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000716	0.00438	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000686	0.0042	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000666	0.00407	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00061	0.00373	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00054	0.0033	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000503	0.00308	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000408	0.0025	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000408	0.00249	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000403	0.00246	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000358	0.00219	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000351	0.00215	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000345	0.00211	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—IYD—hypothyroidism	0.000338	0.00207	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000321	0.00196	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000317	0.00194	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000294	0.0018	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ATP5O—hypothyroidism	0.000288	0.00176	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—POMC—hypothyroidism	0.000287	0.00175	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000282	0.00172	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000277	0.00169	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000272	0.00166	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TPO—hypothyroidism	0.000271	0.00165	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—IYD—hypothyroidism	0.000256	0.00156	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000232	0.00142	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000217	0.00133	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000217	0.00133	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TPO—hypothyroidism	0.000204	0.00125	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000189	0.00116	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TSHB—hypothyroidism	0.000125	0.000766	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	0.000112	0.000683	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TSHB—hypothyroidism	9.46e-05	0.000579	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC5A5—hypothyroidism	9.38e-05	0.000574	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	8.44e-05	0.000516	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.32e-05	0.000509	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC5A5—hypothyroidism	7.08e-05	0.000433	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—POMC—hypothyroidism	4.91e-05	0.0003	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—POMC—hypothyroidism	3.71e-05	0.000227	CbGpPWpGaD
